ABSTRACT: The objective of this article is to evaluate the role of retinoids in the developing head and face. This article covers two lines of evidence that strongly support a role for retinoids in craniofacial development. First, the specific effects of exogenous retinoids on the head and face are covered and mechanisms for the specificity discussed. Second, the function of endogenous retinoids in facial development is discussed in relation to the distribution of retinoid-binding substances in the face. Finally, the interaction of retinoids with other genes known to be expressed in the face as well as other factors required for facial growth is discussed.
I. EARLY ORIGINS OF THE FACE
The embryonic face and head region of vertebrates (including humans, rodents, birds, and fish) is similar at early stages of development (Hall and Horstadius, 1988) . The stomodeum or primitive oral cavity is surrounded by buds of tissue called primordia (Figure 1 ). At the covers of the stomodeum the maxillary primordia are located that form the maxillary bones and palatal shelves. Rostral* to the maxillae are the paired lateral nasal prominences that lie lateral to the nasal pit. These prominences contribute to the conchae of the nose. Medial to the nasal pits are the medial nasal prominences and in the center is the frontonasal mass primordium. The medial nasal prominences form distinct elevations in the mouse and human embryo, whereas in the chick these prominences merge with the frontonasal mass to form one continuous primordium. The frontonasal region, including medial nasal prominences, gives rise to midline structures such as the nasal septum and philtrum. The region below the stomodeum consists of repeating branchial arches, the most rostral of which forms a part of the face. The first branchial arch or mandibular arch lies caudal to the primitive oral cavity and forms the entire lower jaw and part of the maxilla. It is differential growth of the primordia that gives rise to species-specific facial form.
The facial primordia consist of buds of mesenchyme encased in epithelium, the mesenchyme being mostly derived from cranial neural crest cells (Le Lievre, 1978; Noden, 1978; Lumsden et al., 1991) . The mesencephalic/rhombencephalic region of the neural tube gives rise to neural crest cells that migrate into the first branchial arch (reviewed in Le Douarin, 1982) . In birds, more anterior portions of the neural crest, adjacent to the prosencephalon, contribute to the frontonasal mass, lateral nasal prominence, and the cranial aspect of the maxillary mesenchyme. The neural folds in mammals do not give rise to neural crest anterior to the mesencephalon (Tan and Morriss Kay, 1986) . Nonneural crest-derived structures in the head include the jaw-closing muscles, superficial muscles of the face, and the cranial vault. These are formed from the somitomeres of the head (incompletely segmented paraxial mesoderm, Noden, 1988) .
The surface epithelium of the face is derived partially from the neural fold and also from the lateral plate ectoderm (Couly and Le Douarin, 1987; . The neural fold forms the ectoderm of the upper beak in chick embryos, including egg tooth, and the lining of the distal structures of the nose. Lateral plate ectoderm gives rise to the surface epithelium of the lateral nasal prominence, maxilla, and mandible.
II. A FRAMEWORK FOR UNDERSTANDING FACIAL GROWTH AND MORPHOGENESIS

A. Factors Controlling Cell Fate of Cranial Neural Crest before and during Migration
It is hypothesized that facial pattern is set up during three stages of embryonic development: (1) prior to neural crest migration, (2) during migration of neural crest cells, and (3) once neural crest-derived cells come to lie within the facial primordia.
The head and tail of the embryo are determined by the time neural crest cells are identifiable at the dorsal surface of the neural tube. It is likely that anteroposterior polarity in the neural crest also exists in this premigratory stage and that retinoids (Sive et al., 1990) , growth factors (e.g., activins, Smith et al., 1990; Mitrani et al., 1990) , and homeobox-containing genes (Holland, 1988; (Noden, 1983) . Thus, despite the abnormal migratory path, recognizable beak-like structures developed. A related result was obtained in recombinations of mesencephalic neural crest and facial epithelium. The form of the cartilage structures depended on the origin of the neural crest and is predetermined prior to migration (Hall, 1989) .
The path of migration that neural crest cells take also influences subsequent morphogenesis. In Noden's experiments (1983) (Silver, 1962) . Because neural crest cells migrate rostral and caudal to the eye primordium (Johnston, 1966) , removal of the eyes must greatly alter the developmental experiences of the neural crest. Besides directing traffic flow, the epithelia of the eye primordia produce type II collagen (Thorogood et al., 1986; Thorogood, 1988; Wood et al., 1991 [Johnston, 1966; Noden, 1975] 9 to 10 d in mouse embryos [Nichols, 1981 [Nichols, , 1986 ), they proliferate to fill the epithelial jackets. Face shape is determined by a combination of factors: (1) the epithelium that controls outgrowth (Richman and Tickle, 1989) and the induction of bone (Tyler and Hall, 1977; Tyler, 1978; Tyler and McCobb, 1980; Hall, 1980) ; (2) the mesenchyme that controls shape (Richman and Tickle, 1989) ; (3) growth factors that may be involved in differential outgrowth of the primordia (Richman and Crosby, 1990) (Kalter and Warkany, 1959; Heine et al., 1985) . Once delivered to the tissues via the blood, retinol is metabolized to retinal and then into retinoic acid (Thaller and Eichele, 1988 [Thaller and Eichele, 1987; Satre and Kochhar, 1989] 3,4-didehydroretinoic acid [Thaller and Eichele, 1990] (Lammer et al., 1985; Benke, 1984; Hill, 1984; Rosa, 1983 (Werler et al., 1990 ).
Mouse and Rat
The sensitivity of rodents to various forms of retinoids differs from that of humans, and ad-ditional defects in the limbs, primary palate (Goulding and Pratt, 1986) and teeth (Knudson, 1966) (Goulding and Pratt, 1986) just as reported in human embryos. A similar result was obtained with rat embryos (Webster et al., 1986) . The quantitative observation of a reduction in size of the mandible could be a major factor in the production of the cleft palate (Diewert, 1979; Diewert and Pratt, 1979) in addition to direct effects of the retinoids on palatal shelf growth and fusion (Abbott et al., 1989) .
Injecting pregnant rats with vitamin A while neural crest migration is taking place results in the induction of ectopic cartilage in the maxilla (Morriss and Thorogood, 1978) . This was explained by a shortening of the cranial end of the embryo leading to an anterior shifting of the neural crest. Thus, crest cells that would normally migrate into the mandible migrate into the maxilla and form cartilage. A related finding was recently reported by Kessel and Gruss (1991 (Goulding and Pratt, 1986) . Therefore, cleft lip produced by isotretinoin in the mouse is not due to inhibited neural crest migration into the face (see also Section III.4 on the chick face). The limb defects observed in mouse embryos may be due to flattening of the apical ectodermal ridge caused by retinoid acid, a major metabolite of isotretinoin (Creech Kraft et al., 1989) . In chick limb buds, retinoic acid causes flattening of the apical ectodermal ridge and this is directly related to reduced outgrowth (Webster et al., 1986) . Instead, only certain target tissues are affected, whereas others develop normally. The site specificity of retinoids on developing embryos could be related to differential uptake. Indeed, it has been shown that radioactive retinoic acid (Dencker et al., 1987) and synthetic retinoids (Dencker et al., 1990) preferentially accumulate in the neural folds, the maxillae, the medial nasal prominences, and the mandibular primordia of mice, all of which are targets for retinoids. It is important to note, however, that the teratological effects of the synthetic retinoid used by Dencker et al., (1990) have not yet been examined. Therefore, the correlation of target tissues whose development is abnormal with the accumulation of synthetic retinoid in these tissues cannot be carried out.
Regional specificity of the teratogenic effects of retinoids may also be related to differences in responsiveness of cells to retinoids. Two classes of retinoid-binding substances are found intracellularly and these seem to be concentrated in tissues affected by exogenous retinoids. These are discussed in detail in Section III.B.
Xenopus
Systemic administration of retinoic acid to frog embryos leads to truncation of head structures. The total volume of the CNS remains unchanged, yet ventral structures such as eyes and nasal pit do not form (Durston et al., 1989) . Transcripts of genes known to be expressed in the anterior part of the embryo were not detected in retinoic acid-treated embryos, whereas posterior markers for head development continued to be expressed following retinoic acid treatment (Sive et al., 1990) . The target of retinoic acid in the cranial region of the Xenopus embryo is not known. It was originally suggested that retinoic acid acts on the neurectoderm directly (Durston et al., 1989) . However, recent data suggest that the mesoderm is the target of retinoic acid (Altaba and Jessel, 1991) and that interactions between the abnormal mesoderm and the overlying ectoderm cause abnormal neurulation (Papalopulu et al., 1991 (Langille et al., 1989) .
It was possible to study the effects of retinoic acid on form and growth of the primordia in isolation from the rest of the face by grafting individual facial primordia from a treated, donorchick embryo to an ectopic site. These experiments confirmed that outgrowth of the frontonasal mass was affected, but not the mandible (Wedden, 1987) . In addition, epithelial-mesenchymal recombination experiments have determined that retinoic acid acts directly on the mesenchyme and not the epithelium (Wedden, 1987; Tickle et al., 1989 (Horton et al., 1987) and, therefore, retinoic acid could inhibit frontonasal growth by directly inhibiting differentiation of cartilage. However, both the frontonasal mass and the mandible contain large numbers of chondrocytes (Wedden et al., 1986 ), yet only the frontonasal mass chondrocytes are affected. Moreover, cytodifferentiation of chondrocytes takes place long after embryos are irreversibly affected by retinoic acid (Wedden, 1991) (Wolpert, 1989) . The best example of a naturally occurring morphogen is the substance secreted by the polarizing region of the limb bud. The polarizing region (Saunders and Gassling, 1968) located at the posterior* junction of the limb and the flank, sets up a complicated arrangement of cartilage elements (Tickle, 1980) . Grafting a second polarizing region at the anterior margin of the limb bud leads to mirror image duplications. The search for the substances that could perturb the endogenous gradient of polarizing activity led to the discovery of retinoic acid (Tickle et al., 1982; Summerbell, 1983 ; reviewed in Tickle, 1991) . Retinoic acid mimics the natural polarizing region in (1) the effect of position of the graft in the limb bud and (2) the size of the graft on the pattern and number of digits duplicated (Tickle, 1981) . The polarizing region is slightly enriched for retinoic acid compared with anterior bud mesenchyme (Thaller and Eichele, 1987) , which further supports the idea that the polarizing substance is retinoic acid. Recent experiments have altered this view somewhat. It is now thought that retinoic acid induces the production of other signals like those produced by the polarizing region (Wanek et al., 1991 , Tickle, 1991 Noji et al., 1991; reviewed in Tabin 1991 (Benbrook et al., 1988; Brand et al., 1988; Rowe et al., 1991a; Smith and Eichele, 1991) and y Krust et al., 1989) . Retinoic acid receptors (RARs) belong to the steroid hormone receptor family (Green and Chambon, 1988; Evans, 1988) and therefore share a similar arrangement of six functionally distinct domains.
The most conserved of these between the three classes of receptor are the DNA-binding and ligand-binding domains. Expression of each receptor is preferentially stimulated by certain ligands. For example, RAR-P transcription is stimulated 50-fold in the presence of retinoic acid, whereas RAR-a expression is not affected . More recently, several isoforms for RAR-a, (Leroy et al., 1991) RAR-P, (Zelent et al., 1991; Table 1 for summary). In addition to the a, P, and y nuclear receptors, a more distantly related type of receptor, RXR has been isolated from both the rat and the chick (Manglesdorf et al., 1990; Rowe et al., 1991b) . RXR is expressed in some neural crest derivatives but not in the craniofacial mesenchyme (Rowe et (Rowe et al., 1992) . RAR-P is expressed in migrating prosencephalic/mesencephalic neural crest cells at stage 10 and continues to be expressed along the established migration pathways for this population of neural crest (Figure 2 ; A, B, C, Johnston, 1966; Noden, 1975) .
Once the facial primordia are established, those regions of the face principally derived from pro- Expression levels of RAR-P in the chick are very similar in the mandible and caudal part of the maxilla (Rowe et al., 1991a) . Lumsden et al., (1991) did not make injections near the junction of the prosencephalon and mesencephalon; therefore, it is not possible to completely resolve the origins of maxillary mesenchyme.
There are some differences in early RAR-,3 expression in the mouse and chick embryo. In the mouse, RAR-3 transcripts were not detected anterior to rhomobomere 7 in the hindbrain , whereas in the chick, transcripts are found anterior and posterior to the optic primordia and ventral to the mesencephalon (see also Smith and Eichele, 1991) . Expression of RAR-P was not detectable in migrating murine neural crest cells as it was in the chick (Rowe et al., 1992) . These differences between species could reflect differences in origin of neural crest cells. In birds, the prosencephalic region of the neural tube gives rise to some neural crest, whereas in mammals the forebrain makes no contribution to neural crest (Tan and Morris Kay, 1986 Recently, the promoters for the isoforms of mouse RAR-P have been identified (Zelent et al., 1991) . Promoters control the level of transciption of RNA and where transcription takes place. Fusing the RAR-P promoter to a reporter gene such a lacZ allows one to visualize where RAR-P is expressed. The lacZ gene codes for P3-galactosidase, which will metabolize a substrate and create a colored reaction product. The advantage of this technique over in situ hybridization is that message stability in a particular tissue is not a problem and the specific elements that direct regional expression can be identified. Transgenic mice containing a RAR-32 promoter-lacZ fusion construct have been generated . Several differences from the in situ experiments Dolle et al., 1990) were observed, but most relevant to the present discussion was the absence of P-galactosidase activity rostral to the third branchial arch. In contrast, in situ hybridization revealed RAR-P transcripts in the frontonasal mass region of similarly staged embryos. The discrepancy could be due to the promoter lacking elements that control facial expression or that other isoforms of RAR-p are expressed in the face. . This observation can be explained by the presence of a retinoic acid response element in the RAR-P promoter (Hoffmann et al., 1990 , Zelent et al., 1991 . A transgenic mouse containing a retinoic acid response element from the RAR-p gene fused to the lacZ gene and a heat shock promoter exhibited P-galactosidase activity in specific regions of the embryo. The endogenous retinoids are thought to be controlling the expression of P-galactosidase in this construct. After treatment of the mothers with retinoic acid, transgenic embryos had significantly increased levels of expression of the lacZ gene . Similarly, there is a qualitative general increase in expression throughout the chick face of RAR-P following retinoic acid treatment (Rowe et al., 1991a) . In contrast to the mouse, the pattern of RAR-p expression in the chick face is changed in response to retinoic acid treatment. Transcripts are increased in the caudal part of the maxilla (Rowe et al., 199 la) . This was the only region in which a change in distribution of the transcripts was observed.
There is not a strong correlation between induction of RAR-p expression in the maxilla and the observed effects of exogenous retinoids on the face. The maxilla is not a target of retinoic acid, whereas the frontonasal mass is (Tickle and Richman, in preparation). Therefore, is RAR-P mediating the retinoic acid-induced facial defect in chick embryos? An interesting correlation of RAR-p expression and regions of chondrogenesis in the chick face has been noted that may support a role for RAR-P mediating the increased sensitivity of the frontonasal mass to retinoids (Richman and Rowe, unpublished results). The onset of chondrogenesis in the mandible begins at stage 24 as evidenced by accumulation of collagen type II transcripts in the region where Meckel's cartilage will form (Figure 3B) . Very low levels of RAR-P transcripts are found in the area of chondrogenesis ( Figure  3A ) and this distribution is maintained in stage 28 embryos (Figures 3C-F) . The exclusion of RAR-P from Meckel's cartilage is similar to that reported for the cartilage rudiments of the mouse limb bud (Dolle et al., 1989) . In contrast, the region of RAR-P expression in the frontonasal mass overlaps the region expressing type II collagen transcripts (Figures 3C-F (Maden et al., 1988 (Dencker et al., 1990 , Maden et al., 1990 and chick embryos (Vaessen et al., 1990; Maden et al., 1991) . Transcripts for CRABP are found in the primary mesenchyme in the regions where neural crest migration is taking place (Perez Castro et al., 1989; Ruberte et al., 1991) . At later stages of development CRABP is expressed at high levels first in the frontonasal mass and then later in the mandible . CRABP is expressed in a proximo-distal* gradient in the mandible and frontonasal mass ) and could therefore be associated with outgrowth of these two primordia. In addition, CRABP is not expressed in the central core mesenchyme of the mandible and frontonasal mass (Dencker et al., 1990 ; Dolle et al., 1990) . The embryonic origins of the central core are likely to be mesodermal rather than neural crest (Noden, 1987 (Richman and Crosby, 1990) A second approach is to look for correlations between the expression domains of genes expressed in the face (see Table 1 ). Two closely related members of the transforming growth factor family, bone morphogenetic protein-2 and -4 (Lyons et al., 1990; Jones et al., 1991) , a gene related to wingless in Drosophila, Wnt-5a (Gavin et al., 1990) , the transcription factor AP-2 (Mitchell et al., 1991) receptors for basic fibroblast growth factor (Heuer et al., 1990; Wanaka et al., 1991) , and three homeobox-containing genes (Hox 7.1 and Hox 8.1, [Hill et al., 1989; Robert et al., 1989; Mackenzie et al., 1991, Dav- (Davidson et al., 1991) and the same may be true in the face (S. E. Wedden, work in progress) .
A third approach is to perform loss of function experiments. This has already been applied to the Engrailed-2 (Joyner et al., 1991) , Hox 1.58 (Chisaka and Capecchi, 1991) and Hox 1.6 (Lufkin et al., 1991) (Luscher et al., 1989) and Hox 1.6 (LaRosa and Gudas, 1988).
Finally, experiments can be designed to look at cooperativity between several of the genes expressed in the face and molecules like retinoic acid and bFGF that affect facial growth. Experiments of this sort have been carried out in Xenopus and the data show that a combination of growth factors and retinoids is necessary for cor-rect homeobox gene expression in Xenopus embryos (Cho and DeRobertis, 1990 
